Tectonic Therapeutic Inc expected to post a loss of $1.03 a share - Earnings Preview
08/08/2025 12:17
Tectonic Therapeutic Inc TECX.OQ TECX.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending September 30 2025 ​LSEG's mean analyst estimate for Tectonic Therapeutic Inc is for a loss of $1.03 per share. The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts had risen by about 3.3% in the last three months. ​ Wall Street's median 12-month price target for Tectonic Therapeutic Inc is $80.50, about 72.8% above its last closing price of $21.92 Previous quarterly performance (using preferred earnings measure in US dollars). ​
| QUARTER ENDING | STARMINESMARTESTIMATEÂŪ | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
| Jun. 30 2025 | -0.96 | -0.98 | -1.07 | Missed | -9 |
| Mar. 31 2025 | -1.09 | -1.09 | -0.93 | Beat | 14.9 |
| Dec. 31 2024 | -1.39 | -0.84 | Beat | 39.4​ | |
| Sep. 30 2024 | -0.82 | -0.82 | -1.20 | Missed | -45.5 |
| ​​Jun. 30 2024 | -1.40 | -1.50 | -4.34 | Missed | -189.3 |
| Mar. 31 2024 | -4.32 | -4.32 | -1.80 | Beat | 58.3​ |
| Dec. 31 2023 | -4.95 | -4.04 | -2.40 | Beat | 40.6 |
| Sep. 30 2023 | -3.34 | -3.40 | -5.28 | Missed | -55.3 |
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs